{"disease":{"id":"stem-cell-media","name":"stem cell media"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03038672","title":"Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":54,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT05004779","title":"Regenerative Effects of Human Stem Cell Media After Laser Therapy in Hypertrophic Scar","phase":"NA","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Hangang Sacred Heart Hospital","has_results":false},{"nct_id":"NCT02652715","title":"Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma","phase":"NA","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"Mayo Clinic","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}